{
    "code": "02025115",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025115",
    "time": "2021-10-01 03:25:35",
    "許可證字號": "衛署藥輸字第025115號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/11\/24",
    "發證日期": "98\/11\/24",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202511508",
    "中文品名": "複方愛舒壓懸浮液",
    "英文品名": "Azarga Eye drops, suspension",
    "適應症": "用於治療曾使用單方治療效果不佳的隅角開放性青光眼或高眼壓成人患者，以降低其眼內壓。",
    "劑型": "483點眼懸液劑",
    "包裝": "100公撮以下塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "TIMOLOL MALEATE, BRINZOLAMIDE",
    "限制項目": "02輸　入",
    "申請商名稱": "0924601100  台灣諾華股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號8樓",
    "主製造廠": [
        {
            "": "BELGIUM",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1216001910",
            "成分名稱": "TIMOLOL MALEATE",
            "含量描述": "(Equiralent to 5 mg timolo as free base)",
            "含量": "6.8000000000",
            "單位": "MG\/ML"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "5210000400",
            "成分名稱": "BRINZOLAMIDE",
            "含量描述": "",
            "含量": "10.0000000000",
            "單位": "MG\/ML"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "025115_AZARGA Eye Drops, Suspension-108-06-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025115&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "NPI.cht.A3_AZARGA_2020-PSBGLC-1102-s_EET-04Jun2020_TWI-301020_clean_202010-109-11-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025115&Seq=006&Type=9"
        },
        {
            "title": "04.2_FB-LBL_Azarga_202007-109-11-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025115&Seq=008&Type=8"
        }
    ]
}